# Bioequivalence Study of Pantoprazole 40 mg DR Tablets and Protonix 40 mg Tablets Under Fed Conditions

> **NCT01179659** · PHASE1 · COMPLETED · sponsor: **Kremers Urban Development Company** · enrollment: 150 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Pantoprazole 40 mg DR Tablet vs. Protonix 40 mg DR Tablet

## Key facts

- **NCT ID:** NCT01179659
- **Lead sponsor:** Kremers Urban Development Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2005-11
- **Final completion:** 2006-03
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2010-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01179659

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01179659, "Bioequivalence Study of Pantoprazole 40 mg DR Tablets and Protonix 40 mg Tablets Under Fed Conditions". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT01179659. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*